Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06103396
Other study ID # IVIC-UTC-MSC-Pseudarthrosis
Secondary ID
Status Enrolling by invitation
Phase Phase 1/Phase 2
First received
Last updated
Start date January 30, 2018
Est. completion date December 30, 2024

Study information

Verified date October 2023
Source Instituto Venezolano de Investigaciones Cientificas
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to evaluate the bone regeneration capacity of BM-MSC (Bone marrow mesenchymal stromal cells), in patients with nonunion. BM-MSC cultured are seeded on a collagen scaffold, included into autologous platelet-rich plasma (PRP) clot, and implanted in the nonunion bone defect.


Description:

Nonunion (pseudoarthrosis) is one of the most serious complications of bone fracture. Even though different treatments have been used to repair nonunion bone defects, most of them have limitations, like morbidities, limited supply, frequent treatment failure, and high cost. Based on the knowledge that MSC have multipotential capacity of differentiation into bone, cartilage, fat, and endothelial cells, and also, play a key role in the process of bone formation and fracture repair. In this study, we evaluated the use the bone regeneration capacity of autologous or allogeneic BM-MSC, as a potential therapeutic strategy to induce formation of new bone tissue and fracture healing. A bioengineering construct, constituted by MSCs and a collagen scaffold, is incorporated into platelet rich plasma (PRP) clot, wich is implanted at the nonunion site defect.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 30
Est. completion date December 30, 2024
Est. primary completion date January 30, 2022
Accepts healthy volunteers No
Gender All
Age group 10 Years to 85 Years
Eligibility Inclusion Criteria: - Post-traumatic nonunion diagnosis (Pseudoarthrosis) with or without previous ortopaedic treatment - Patients with or without previous orthopaedic treatment - Presence of nonunion 9 month or more - Ossification failure in the non-union area, with an approximate size of 0.5 to 4 cm length Exclusion Criteria: - Evidence of infection at the nonunion site (Osteomielitis) - Evidence of cutaneous lesion at the site of pseudoartrosis - Viral hepatitis B and C, HIV infection, syphilis and other viral and bacterial infections - Autoimmune diseases - Neoplastic diseases - Pregnancy - Major metabolic disorders - Treatment with steroids - Other conditions or circumstances that compromise the study participation according to medical criteria

Study Design


Intervention

Biological:
Transplantation of autologous MSCs in nonunion fracture
At surgery, fibrotic tissue is removed from the nonunion sites. MSCs/Col/PRP clots are implanted in the site of nonunion. Patients received conventional orthopedic treatment as they needed (osteotomy, external and/or internal fixation systems, etc.)
Transplantation of allogeneic MSCs in nonunion fracture
At surgery, fibrotic tissue is removed from the nonunion sites. MSCs/Col/PRP clots are implanted in the site of nonunion. Patients received conventional orthopedic treatment as they needed (osteotomy, external and/or internal fixation systems, etc.)

Locations

Country Name City State
Venezuela Instituto Venezolano de Investigaciones Cientificas Caracas Miranda

Sponsors (3)

Lead Sponsor Collaborator
Instituto Venezolano de Investigaciones Cientificas Hospital Central Dr. Plácido D. Rodriguez Rivero, Instituto Autónomo Hospital Universitario de la Universidad de Los Andes

Country where clinical trial is conducted

Venezuela, 

References & Publications (3)

Diaz-Solano D, Wittig O, Mota JD, Cardier JE. Isolation and Characterization of Multipotential Mesenchymal Stromal Cells from Congenital Pseudoarthrosis of the Tibia: Case Report. Anat Rec (Hoboken). 2015 Oct;298(10):1804-14. doi: 10.1002/ar.23198. Epub 2015 Jul 30. — View Citation

Wittig O, Diaz-Solano D, Cardier J. Viability and functionality of mesenchymal stromal cells loaded on collagen microspheres and incorporated into plasma clots for orthopaedic application: Effect of storage conditions. Injury. 2018 Jun;49(6):1052-1057. doi: 10.1016/j.injury.2018.04.005. Epub 2018 Apr 5. — View Citation

Wittig O, Romano E, Gonzalez C, Diaz-Solano D, Marquez ME, Tovar P, Aoun R, Cardier JE. A method of treatment for nonunion after fractures using mesenchymal stromal cells loaded on collagen microspheres and incorporated into platelet-rich plasma clots. Int Orthop. 2016 May;40(5):1033-8. doi: 10.1007/s00264-016-3130-6. Epub 2016 Mar 16. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical evaluation Time of surgical wound evolution, surgically intervened limb evolution, movility Baseline, 1 and 7 days. 1, 2 and 6 months. 1 and 2 years
Primary Bone consolidation Time of development changes in bone consolidation by radiological studies Baseline, 1 and 7 days. 1, 2 and 6 months. 1 and 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT03970941 - Two-stage Treatment of Large Bone Defects With Cerament® G and Cerament® V Plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy After Bone Resection in Patients With Septic Pseudarthrosis
Terminated NCT01461005 - A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS) N/A
Terminated NCT00424567 - Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures. Phase 1/Phase 2
Completed NCT04200872 - Observational Retrospective Study on the Clinical and Radiographic Outcomes of the Aseptic Pseudarthrosis Treatment of the Upper Limb
Completed NCT00916981 - Treatment of Atrophic Nonunion by Preosteoblast Cells Phase 1/Phase 2
Recruiting NCT05583864 - Lumbar Fusion With Porous Versus Non-Porous Cages N/A
Recruiting NCT05483387 - Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments. Phase 4
Completed NCT04418882 - Septic Management and Outcome of Open Fracture
Not yet recruiting NCT01756144 - rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport N/A
Terminated NCT03382665 - Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction
Recruiting NCT06098157 - Tuebingen Register of Union Failure After Fractures of the Upper and Lower Extremities
Recruiting NCT02683252 - Musculoskeletal Non-tumoral Pathology Quantitative Perfusion N/A
Completed NCT00726128 - Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System